» Articles » PMID: 28987047

[Epidemiology and Risk Factors of Hepatocellular Carcinoma]

Overview
Specialty General Medicine
Date 2017 Oct 8
PMID 28987047
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Primary liver neoplasms occurs relatively rarely in Poland. The most frequently occurring type of cancer is hepatocellular carcinoma (HCC), which globally constitutes 7% of all the occurrences of cancer. The incidence increases with age and is the highest in patients around the age of 70. It also varies significantly depending on the geographic location. The main factors that cause HCC are infection of HBV and HCV, whose genome integrates into the DNA of the host, causing mutations. The other factors include excessive alcohol consumption, contact or consumption of Aspergillus toxins as well as various metabolic disorders, such as α1-antitrypsin deficiency, hemochromatosis, tyrosinemia, porphyria, von Gierke disease and in person with gene mutation p.I148M of adiponutrin. HCC is usually detected incidentally, during ultrasound examination or during clinical diagnosis of liver failure. HCC can be diagnosed using computed tomography (CT) or magnetic resonance imaging (MRI), which is considered the most accurate diagnostic method. A core needle biopsy or the examination of the level of markers such as: alpha-fetoprotein (AFP), D-gamma-carboxy prothrombin (DCP), tumourassociated glycoprotein 72 (CA 72-4, TAG-72), are advised for a complete diagnostics.

Citing Articles

Construction of m7G RNA modification-related prognostic model and prediction of immune therapy response in hepatocellular carcinoma.

Wang H, Shui X, Zhang Z, He M, Tai S, Lin Y Transl Cancer Res. 2024; 13(6):2799-2811.

PMID: 38988942 PMC: 11231774. DOI: 10.21037/tcr-24-22.


Efficacy and safety analysis of TACE + Donafenib + Toripalimab versus TACE + Sorafenib in the treatment of unresectable hepatocellular carcinoma: a retrospective study.

Lu H, Liang B, Xia X, Zheng C BMC Cancer. 2023; 23(1):1033.

PMID: 37880661 PMC: 10599044. DOI: 10.1186/s12885-023-11535-5.


Tumor cuproptosis and immune infiltration improve survival of patients with hepatocellular carcinoma with a high expression of ferredoxin 1.

Quan Y, Li W, Yan R, Cheng J, Xu H, Chen L Front Oncol. 2023; 13:1168769.

PMID: 37361595 PMC: 10285401. DOI: 10.3389/fonc.2023.1168769.


The Emerging Role of EVA1A in Different Types of Cancers.

Zhao H, Liu H, Yang Y, Wang H Int J Mol Sci. 2022; 23(12).

PMID: 35743108 PMC: 9224241. DOI: 10.3390/ijms23126665.


Correlation of CT Perfusion Parameters and Vascular Endothelial Growth Factor (VEGF) and Basic Fibroblast Growth Factor (BFGF) in Patients with Primary Liver Cancer.

Li X, Chen W, Zhang J, Ma L, Li Q, Feng C Evid Based Complement Alternat Med. 2022; 2022:4548922.

PMID: 35656468 PMC: 9155910. DOI: 10.1155/2022/4548922.